- Report
- October 2022
- 41 Pages
Global
From €3340EUR$3,500USD£2,799GBP
- Report
- September 2022
- 295 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- May 2022
- 843 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- May 2022
- 61 Pages
Global
From €1909EUR$2,000USD£1,599GBP
- Report
- January 2025
- 132 Pages
Global
From €907EUR$950USD£760GBP
- Report
- November 2021
- 844 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- July 2022
- 220 Pages
Global
From €3407EUR$3,570USD£2,855GBP
- Report
- September 2021
- 187 Pages
Global
From €3543EUR$3,712USD£2,968GBP
- Report
- October 2022
- 229 Pages
Global
From €3407EUR$3,570USD£2,855GBP
The Antipsychotic Drug market is a segment of the Central Nervous System Drugs market. Antipsychotic drugs are used to treat mental disorders such as schizophrenia, bipolar disorder, and major depressive disorder. These drugs work by blocking dopamine receptors in the brain, which helps to reduce the symptoms of psychosis. Common side effects of antipsychotic drugs include drowsiness, weight gain, and dry mouth.
The Antipsychotic Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Eli Lilly, Pfizer, Johnson & Johnson, Novartis, and AstraZeneca. These companies have a wide range of products, including both branded and generic drugs. Additionally, many of these companies have developed new formulations of existing drugs, such as long-acting injectables, to improve patient compliance. Show Less Read more